UCSF Team at 2022 Multidisciplinary NET Medical Symposium

December 01, 2022
UCSF representation at the 2022 Multidisciplinary NET Medical Symposium October 27-29 in Washington, D.C.

Claire Mulvey, MD receives Spring 2022 RAP Funding for eNet Study

August 16, 2022
Claire Mulvey, MD, Assistant Professor of Medicine, UCSF, received funds from the Spring 2022 Research Allocation Project (RAP) for her project "eNET: a Web-Based Health Platform to Investigate Quality of Life in Patients with Neuroendocrine Tumors."

New eNET Study Open

May 18, 2021
eNET is a study to test the effectiveness of a Web-based program to collect information about symptoms, lifestyle, quality of life, and well-being for patients with neuroendocrine tumors. It is being run by Dr. Emily Bergsland and doctors at UCSF. To learn more or sign up, go to enet....

Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer

By on August 21, 2020
Charles Ryan invites Rahul Aggarwal to discuss treatment-emergent small-cell neuroendocrine prostate cancer, an area not well characterized in the era of modern androgen receptor (AR)-targeting therapy.  

NETRF funds $3.5 million in research to advance neuroendocrine tumor treatment

By Neuroendocrine Tumor Research Foundation (NETRF) on February 13, 2020
UCSF's Claire Mulvey, MD, has been awarded a Fellowship Award from the Neuroendocrine Tumor Research Foundation (NETRF) for her project "Trends in incidence and survival outcomes for lung NETs."  The Neuroendocrine Tumor Research Foundation (NETRF), Boston, MA, today announced $3.5 million in...

PET offers more precise screening method to select candidates for radionuclide therapy

By on October 08, 2019
A new study published in The Journal of Nuclear Medicine evaluated the role of 68Ga-DOTATATE positron emission tomography/computed tomography (PET/CT) in selecting neuroendocrine tumor patients who may benefit from peptide receptor radionuclide therapy (PRRT).

2019 Neuroendocrine Tumor Patient Conference

July 26, 2019
Presented by the UCSF Helen Diller Family Comprehensive Cancer Center and NorCal CarciNET Community, in collaboration with Stanford University and with generous support provided by supporters and industry partners. Co-Host: NorCal CarciNET Community  Sunday, February 10, 2019 at 8:30am to 5:00am...

NETRF Announces $2.5 Million in Research to Advance the Treatment of Neuroendocrine Tumors

By Donna Dubuc, Director of Communications, NETRF on February 05, 2019
(Boston, MA) — The Neuroendocrine Tumor Research Foundation (NETRF) continues its aggressive funding of neuroendocrine cancer research with eight new grants totaling $2.5 million. With this newest round of funding, NETRF expands its portfolio to include research into lung neuroendocrine tumors (...